Funding will accelerate the company's anti-amyloid treatment for rare and common forms of dementia.As well as bringing forward a new class of treatment for inflammatory skin diseases.Sanos Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback